Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

Carolyn Y. Ho, Sharlene M. Day, Anna Axelsson Raja, Mark W. Russell, Kenneth Zahka, Harry M. Lever, Alexandre C. Pereira, Steven D. Colan, Renée Margossian, Anne M. Murphy, Charles E. Canter, Richard G. Bach, Matthew T. Wheeler, Joseph W. Rossano, Anjali Owens, Henning Bundgaard, Lee Benson, Luisa Mestroni, Matthew R.G. Taylor, Amit R. Patel, Ivan Wilmot, Philip T. Thrush, Jose D. Vargas, Jonathan H. Soslow, Jason R. Becker, Christine E. Seidman, Neal K. Lakdawala, Allison L. Cirino, VANISH Investigators, José Eduardo Krieger, Luciana Sacilotto, Edmundo Arteaga, Murilo O. Antunes, E. Kevin Hall, Lubna Choudhury, Elfriede Pahl, Kimberly Y. Lin, Gregory D. Lewis, Akshay S. Desai, Kristin M. Burns, John J.V. McMurray, Calum A. MacRae, Scott D. Solomon, E. John Orav, Eugene Braunwald